Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2004 6
2005 7
2006 3
2007 5
2008 3
2009 9
2010 2
2011 5
2012 14
2013 10
2014 10
2015 7
2016 16
2017 13
2018 13
2019 23
2020 24
2021 29
2022 37
2023 46
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Results by year

Filters applied: . Clear all
Page 1
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper.
Abdul-Aziz MH, Alffenaar JC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, Neely MN, Paiva JA, Pea F, Sjovall F, Timsit JF, Udy AA, Wicha SG, Zeitlinger M, De Waele JJ, Roberts JA; Infection Section of European Society of Intensive Care Medicine (ESICM); Pharmacokinetic/pharmacodynamic and Critically Ill Patient Study Groups of European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Infectious Diseases Group of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT); Infections in the ICU and Sepsis Working Group of International Society of Antimicrobial Chemotherapy (ISAC). Abdul-Aziz MH, et al. Among authors: zeitlinger m. Intensive Care Med. 2020 Jun;46(6):1127-1153. doi: 10.1007/s00134-020-06050-1. Epub 2020 May 7. Intensive Care Med. 2020. PMID: 32383061 Free PMC article. Review.
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial.
Wunderink RG, Matsunaga Y, Ariyasu M, Clevenbergh P, Echols R, Kaye KS, Kollef M, Menon A, Pogue JM, Shorr AF, Timsit JF, Zeitlinger M, Nagata TD. Wunderink RG, et al. Among authors: zeitlinger m. Lancet Infect Dis. 2021 Feb;21(2):213-225. doi: 10.1016/S1473-3099(20)30731-3. Epub 2020 Oct 12. Lancet Infect Dis. 2021. PMID: 33058798 Clinical Trial.
Protein binding: do we ever learn?
Zeitlinger MA, Derendorf H, Mouton JW, Cars O, Craig WA, Andes D, Theuretzbacher U. Zeitlinger MA, et al. Antimicrob Agents Chemother. 2011 Jul;55(7):3067-74. doi: 10.1128/AAC.01433-10. Epub 2011 May 2. Antimicrob Agents Chemother. 2011. PMID: 21537013 Free PMC article. Review.
EACPT Virtual Meeting 2021.
Zeitlinger M. Zeitlinger M. Eur J Clin Pharmacol. 2021 Jun;77(Suppl 1):1-42. doi: 10.1007/s00228-021-03164-3. Eur J Clin Pharmacol. 2021. PMID: 34173020 Free PMC article. No abstract available.
Research priorities towards precision antibiotic therapy to improve patient care.
Bulman ZP, Wicha SG, Nielsen EI, Lenhard JR, Nation RL, Theuretzbacher U, Derendorf H, Tängdén T, Zeitlinger M, Landersdorfer CB, Bulitta JB, Friberg LE, Li J, Tsuji BT; International Society of Anti-Infective Pharmacology; European Society of Clinical Microbiology and Infectious Diseases Pharmacokinetics and Pharmacodynamics of Anti-Infectives Study Group; International Society of Antimicrobial Chemotherapy Anti-Infective Pharmacology Working Group. Bulman ZP, et al. Among authors: zeitlinger m. Lancet Microbe. 2022 Oct;3(10):e795-e802. doi: 10.1016/S2666-5247(22)00121-5. Epub 2022 Jun 28. Lancet Microbe. 2022. PMID: 35777386 Free article. Review.
278 results